Clinical Trials Sponsored by Asia Stem Cell Regenerative Pharmaceutical Co., Ltd.
Total 1 results
-
Asia Stem Cell Regenerative Pharmaceutical Co.,...Recruiting
Sponsors and Collaborators
- Diego Hernan Giunta, MD
- ProteoSys AG
- Norsk Proteinintolerance, Norway
- Donders Institute for Brain, Cognition and Behavior
- AMTC & Associates
- The Fifth Affiliated Hospital of Zunyi Medical College
- Ilustre Colegio Profesional de Fisioterapeutas de la Comunidad de Madrid
- University Centre for Chronic Diseases Dekkerswald, Groesbeek, NL
- Fondren Orthopedic Group L.L.P.
- San MediTech(Huzhou)Co.,Ltd.
- Caritas Freetown
- Rui-hua Xu, MD, PhD
- Victor Montori
- Societa Italiana di Endoscopia Digestiva
- Elim Pediatric Pharmaceuticals Inc.
- Cardresearch
- Celtaxsys Aus Pty Limited
- University Medical Center Goettingen
- Alberta Children's Hospital, Calgary, Canada
- CRMBM-CEMEREM
- View Full List
Medical Conditions
- Postcomatose Unawareness State
- Normal Diameter of Optic Nerve
- Plasmodium Falciparum Malaria (Drug Resistant)
- Atrial Fibrillation, Postoperative
- Malignant Ascites Due to Epithelial Carcinoma
- Fibromyalgia Syndrome, Primary
- Prostate Cancer Recurrent
- Tularaemia
- Analgesics, Antipyretics, and Antirheumatics Causing Adverse Effects in Therapeutic Use
- Stereotactic Radioablation for Ventricular Tachycardia
- Auditory Hallucination, Verbal
- Fever, Sweats, and Hot Flashes
- Disturbance of Activity and Attention
- Tube Disorders Eustachian
- Non-compressible Torso Hemorrhage
- Gynecologic Cancer
- Lymphedema of Arm
- Orbital Tumor
- Non-dystrophic Myotonias
- Spermatogenesis Arrest
- View Full List
Drug Interventions
- Oxycodone, fentanyl
- Mupirocin Calcium
- Enzalutamide, Abiraterone
- Lamivudine
- Indoximod
- Polyethylene glycol 3350
- Cetrorelix 78 mg + 78 mg
- CTx-1301-Dexmethylphenidate 18.75mg (randomized fixed dose)
- SERETIDE Diskus
- Topotecan
- Bortezomib/dexamethasone
- Insulin
- Cytarabine ARA-C
- Methotrexate
- Epimedium Prenylflavonoids Extract
- Atezolizumab
- HB-202 / HB-201 alternating intravenous administration + standard of care regimen including pembrolizumab.
- Flibanserin 100 mg dose every evening
- Ruxolitinib
- PF-00868554
- View Full List
CROs by country
- Contract Research Organizations in Cambodia
- Contract Research Organizations in China
- Contract Research Organizations in Ecuador
- Contract Research Organizations in Equatorial Guinea
- Contract Research Organizations in France
- Contract Research Organizations in Kazakhstan
- Contract Research Organizations in Mauritius
- Contract Research Organizations in Morocco
- Contract Research Organizations in Panama
- Contract Research Organizations in Papua New Guinea
- Contract Research Organizations in Singapore
- Contract Research Organizations in Türkiye
- Contract Research Organizations in United Arab Emirates
- CRO list by country